Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Rheumatology (Oxford, England)|April 17, 2015
Quality indicators in rheumatoid arthritis: results from the METEOR databaseVictoria Navarro-Compán, Josef S Smolen, Tom W J Huizinga, et al.
Seminars in Arthritis and Rheumatism|August 13, 2013
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progressionMaurizio Pieroni, Maria De Santis, Gaetano Zizzo, et al.
Clinical and Experimental Rheumatology|May 19, 2017
Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational studyRoberto Caporali, Luca Idolazzi, Stefano Bombardieri, et al.
Rheumatology (Oxford, England)|June 25, 2015
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer riskGiacomo De Luca, Silvia L Bosello, Giorgia Berardi, et al.
Frontiers in Medicine|July 19, 2018
Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound FeaturesStefano Alivernini, Barbara Tolusso, Luca Petricca, et al.
Frontiers in Medicine|November 16, 2020
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination TherapiesLuca Petricca, Maria Rita Gigante, Annamaria Paglionico, et al.
Autoimmunity Reviews|October 20, 2018
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian expertsEnnio Giulio Favalli, Andrea Becciolini, Roberto Caporali, et al.
Plos One|August 4, 2012
Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesisGianfranco Ferraccioli, Barbara Tolusso, Francesca Bobbio-Pallavicini, et al.
Annals of the Rheumatic Diseases|July 14, 2006
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effectsFlorenzo Iannone, Francesco Trotta, Carlomaurizio Montecucco, et al.
Clinical and Experimental Rheumatology|September 1, 2010
Development of a five-year mortality model in systemic sclerosis patients by different analytical approachesLorenzo Beretta, Alessandro Santaniello, Francesca Cappiello, et al.
Pageof 20